Third Harmonic Bio Announces Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire) - Mar 27, 2025 - "R&D Expenses: Research and development (R&D) expenses increased to $10.5 million for the three months ended December 31, 2024, from $5.9 million for the same period in 2023. R&D expenses for the year ended December 31, 2024 increased to $36.5 million, from $24.0 million for the same period in 2023. The increases were primarily due to increased spend related to the THB335 program and increased personnel-related expenses..."
Commercial • Chronic Spontaneous Urticaria
|